| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 09/24/2002 | US6455544 Use of cholinesterase inhibitors to treat disorders of attention |
| 09/24/2002 | US6455543 Cis-2,6-disubstituted piperidines for the treatment of psychostimulant abuse and withdrawal, eating disorders, and central nervous system diseases and pathologies |
| 09/24/2002 | US6455542 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/24/2002 | US6455538 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocin-10-ols |
| 09/24/2002 | US6455531 Metalloproteinase inhibitors |
| 09/24/2002 | US6455529 Adhesion receptor antagonists |
| 09/24/2002 | US6455527 High affinity ligands for nociceptin receptor ORL-1 |
| 09/24/2002 | US6455502 Compounds and compositions as protease inhibitors |
| 09/24/2002 | US6455472 Herbicides, acaricides, nematicides and insecticides for crops |
| 09/23/2002 | WO2001070689A1 DIPHENYLALKYLAMINE DERIVATIVES USEFUL AS OPIOID δ RECEPTOR AGONISTS |
| 09/23/2002 | CA2404280A1 Diphenylalkylamine derivatives useful as opioid .delta. receptor agonists |
| 09/19/2002 | WO2002072577A2 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors. |
| 09/19/2002 | WO2002072570A2 Non-imidazole compounds as histamine h3 antagonists |
| 09/19/2002 | WO2002072559A1 Process to intermediates for biologically active compounds |
| 09/19/2002 | WO2002072552A1 Method for preparing amlodipine |
| 09/19/2002 | WO2002072550A1 Substituted dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-yl methyl]-amines and the use of the same as analgesics |
| 09/19/2002 | WO2002072538A1 Improved method for producing sulfonyl carboxamide derivatives |
| 09/19/2002 | WO2002072093A2 Use of dual h3/m2 antagonists with a bipiperidinic structure in the treatment of cognition deficit disorders |
| 09/19/2002 | WO2002072083A1 Novel inhibitors of formation of advanced glycation endproducts (ages) |
| 09/19/2002 | WO2002062308A3 Primary intermediates for oxidative coloration of hair |
| 09/19/2002 | WO2002053533A3 Kappa opioid receptor ligands |
| 09/19/2002 | WO2002036123A3 New treatments for restless legs syndrome |
| 09/19/2002 | WO2001007020A3 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof |
| 09/19/2002 | US20020133018 Calcium channel blockers; cardiovascular disorders; side effect reduction |
| 09/19/2002 | US20020133014 Reacting 4-pyridinone with glycine |
| 09/19/2002 | US20020133013 Reacting halobenzoic acid with 2,2,2-trifluoroethanol; thenhaloacetonitrile |
| 09/19/2002 | US20020133012 Therapy for neurokinin sensitive disease |
| 09/19/2002 | US20020133011 Alcoholism, psychological disorders |
| 09/19/2002 | US20020133005 Heterocyclic compounds and medical use thereof |
| 09/19/2002 | US20020132973 Peptide parathyroid hormone analogs |
| 09/19/2002 | US20020132834 Subjecting a pyrrole derivative, methyl aminocrotonate and 2-chlorobenzaldehyde to a Hantzsch reaction, and converting the pyrrole residue of the resulting product to an amine group by the action of hydroxylamine hydrochloride. |
| 09/19/2002 | US20020132830 Use of beta 2 bronchodilator drugs |
| 09/19/2002 | US20020132828 N-substituted-4-(m-hydroxyphenyl)piperidine derivated and esters thereof, used to bind a kappa opioid receptor; treating drug addiction |
| 09/19/2002 | US20020131951 Biodegradable poly(beta-amino esters) and uses thereof |
| 09/19/2002 | DE10113027A1 3-Diaminophenyl-acrylamide derivatives or their physiologically acceptable, water-soluble salts, used as developers in combination with couplers in oxidative dye formulations, especially for dyeing hair are new |
| 09/19/2002 | DE10112768A1 New heterocyclic-substituted phenyl compounds, are Factor Xa and Factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, inflammation, restenosis or tumor diseases |
| 09/19/2002 | DE10112198A1 Substituierte Dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-ylmethyl]-amine Substituted dimethyl- [1- (1-phenyl-cyclohexyl) -piperidin-3-ylmethyl] -amines |
| 09/19/2002 | DE10058461A1 Substituierte Cyclohexanderivate und ihre Verwendung Substituted cyclohexane derivatives and their use |
| 09/19/2002 | CA2440758A1 Substituted dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-ylmethyl]-amines |
| 09/19/2002 | CA2436083A1 Use of dual h3/m2 antagonists in the treatment of cognition deficit disorders |
| 09/18/2002 | EP1241168A1 Human NK3 receptor-selective antagonist compounds, process for their obtention and pharmaceutical compositons containing them |
| 09/18/2002 | EP1240154A1 Serine protease inhibitors |
| 09/18/2002 | EP1240143A1 New modulators of dopamine neurotransmission |
| 09/18/2002 | EP1240142A1 New modulators of dopamine neurotransmission |
| 09/18/2002 | EP1240141A1 New modulators of dopamine neurotransmission |
| 09/18/2002 | EP1240140A1 Method for the production of n-alkenyl amides |
| 09/18/2002 | EP1240139A1 Method for producing n-alkenyl amides |
| 09/18/2002 | EP0988273B1 Polymerization inhibition of acrylates using blends of nitroxides |
| 09/18/2002 | EP0891962B1 Process for the preparation of fluorinated dicarbonyl compounds |
| 09/18/2002 | EP0804427B1 Lta4 hydrolase inhibitors |
| 09/18/2002 | CN1370144A Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 09/18/2002 | CN1370048A Azabicyclo and azacyclo oxime and amine compounds as pesticides |
| 09/18/2002 | CN1091108C Diphenylmethylene piperidine derivatives, its prepn. medicinal compsns. contg. them and application thereof |
| 09/18/2002 | CN1091101C Substituted piperidine derivative and medicine contg. same |
| 09/17/2002 | US6452016 Process for the preparation of 1,2,3,6-tetrahydro-2,2,6,6-tetramethylpyridine N-oxide |
| 09/17/2002 | US6452013 For treating conditions which are related to impairment of gastric emptying |
| 09/17/2002 | US6452012 3-phenyl-2,6-dioxopiperidin-3-ylpropionamide derivatives and method for preparing same |
| 09/17/2002 | US6452011 Process for production of piperidine derivatives |
| 09/17/2002 | US6451843 Arylphenyl-substituted cyclic keto enols |
| 09/17/2002 | US6451842 Cyclic amine derivatives and their use as drugs |
| 09/17/2002 | US6451829 Coumarinic compounds having IgE affecting properties |
| 09/17/2002 | US6451824 Sulfonylaminocarboxylic acids |
| 09/17/2002 | US6451822 3-(Amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of HIV related diseases |
| 09/17/2002 | US6451819 Pyrrolidine-3-yl-sulfanyl, or sufonyl or sufinyl derivatives used in the treatment of neurodegenerative diseases |
| 09/17/2002 | US6451814 Heterocyclic β-3 adrenergic receptor agonists |
| 09/17/2002 | US6451803 N-acyl and n-aroyl aralkyl amides useful in treating seritonergic disorders |
| 09/17/2002 | US6451797 Piperidine derivatives |
| 09/17/2002 | US6451791 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/17/2002 | US6451789 Central nervous system disorders; cognition activators |
| 09/17/2002 | US6451736 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 09/17/2002 | CA2042974C Use of a 1-(2-naphthylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for the manufacture of a medicament for the treatment of cerebral and neuronal diseases |
| 09/12/2002 | WO2002070541A2 Peptide deformylase inhibitors |
| 09/12/2002 | WO2002070511A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 09/12/2002 | WO2002070481A1 Hydroxy-substituted n-alkoxy hindered amines and compositions stabilized therewith |
| 09/12/2002 | WO2002070480A1 Glutarimide derivatives as therapeutic agents |
| 09/12/2002 | WO2002070479A1 N-4-piperidinyl compounds as ccr5 modulators |
| 09/12/2002 | WO2002070473A2 Carboxamide derivatives as therapeutic agents |
| 09/12/2002 | WO2002070471A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
| 09/12/2002 | WO2002069973A1 Piperidine-piperazine ligand for neurotransmitter receptors |
| 09/12/2002 | WO2002069901A2 Cathepsin cysteine protease inhibitors |
| 09/12/2002 | WO2002069895A2 Heterocyclic analgesic compounds and methods of use thereof |
| 09/12/2002 | WO2001049721A3 Bacterial genes and proteins that are essential for cell viability and their uses |
| 09/12/2002 | US20020128482 Process for the synthesis of 2,2,6,6-tetramethyl-4-oxopiperidine |
| 09/12/2002 | US20020128476 Inhibitors of cysteine protease |
| 09/12/2002 | US20020128406 Process for polymerizing unsaturated polyalkylpiperidines |
| 09/12/2002 | US20020128315 Amidinophenol derivatives as leukotriene B4 (LTB4)antagonists, phospholipase A2 inhibitors, and trypsin inhibitors. |
| 09/12/2002 | US20020128308 Useful as medicines having an osteogenesis promoting effect and chondrogensis promoting effect. |
| 09/12/2002 | US20020128297 Amlodipine hemimaleate |
| 09/12/2002 | US20020128269 Piperazine derivatives |
| 09/12/2002 | US20020128255 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques |
| 09/12/2002 | US20020128208 Such as 4-benzoylamino-(2-(2-hydroxyethyl)-piperazin-1-yl-methyl)-phenyl)-benzene -sulfonamide; for treatment of hypertension; treatment of kidney disorders |
| 09/12/2002 | US20020127249 Novel formulation for use in pain management |
| 09/12/2002 | US20020127202 Compounds and compositions for delivering active agents |
| 09/12/2002 | US20020127180 Reagents for the determination of cerebral regional acetylcholinesterase activity |
| 09/12/2002 | US20020124980 Inhibition of pulp and paper yellowing using nitroxides, hydroxylamines and other coadditives |
| 09/12/2002 | US20020124326 Contacting the substrate with a mono-, di-, or trialkoxy-substituted perfluoroalkane, perfluorocycloalkane, or perfluorocycloalkyl(ene)- containing perfluoroalkane |
| 09/12/2002 | CA2439827A1 Peptide deformylase inhibitors |
| 09/12/2002 | CA2439644A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
| 09/12/2002 | CA2437594A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 09/11/2002 | EP1238970A1 Cycloamine ccr5 receptor antagonists |